Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - Marker Therapeutics, Inc. | v335976_ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
February 6, 2013
Date of Report (Date of earliest event reported)
TAPIMMUNE INC.
(Exact name of registrant as specified in its charter)
| Nevada | 000-27239 | 88-0277072 |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| 1551 Eastlake Avenue East, Suite 100, Seattle, WA | 98102 | |
| (Address of principal executive offices) | (Zip Code) |
(206) 504-7278
Registrant’s telephone number, including area code
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Effective as of February 6, 2013, James W. Fuller has resigned from his position as a director of our company. This resignation did not result from any dispute or disagreement with us, our independent accountants, our counsel or our operations, policies and practices.
SECTION 9 - FINANCIAL STATEMENTS AND EXHIBITS
| Item 9.01 | (d)Exhibits. |
| Exhibit | Exhibit Description |
| 99.1 | Letter of Resignation from James Fuller, dated February 6, 2013 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TAPIMMUNE INC. | |
| Date: February 20, 2013 |
By: /s/ Glynn Wilson Name: Glynn Wilson Title: Chairman and CEO |